Erratum: SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice (Proceedings of the National Academy of Sciences of the United States of America (2018) 115 (E1769–E1778) DOI: 10.1073/pnas.1720739115);SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 8, 2018, Pages E1769-E1778

  Jenkitkasemwong, Supak ^a   Akinyode, Adenike ^a   Paulus, Elizabeth ^a   Weiskirchen, Ralf ^b   Hojyo, Shintaro ^c   Fukada, Toshiyuki ^d,e,f   Giraldo, Genesys ^g   Schrier, Jessica ^g   Garcia, Armin ^g   Janus, Christopher ^g   Giasson, Benoit ^g   Knutson, Mitchell D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^d TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^e SHOWA UNIVERSITY   (Japan)

^f Institute of Physical and Chemical Research   (Japan)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Liver; Manganese; Pancreas; SLC39A14

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; MANGANESE; MANGANESE 54; SLC39A14 PROTEIN; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; MANGANESE-54; RADIOISOTOPE; SLC39A14 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BIOACCUMULATION; BONE LEVEL; BRAIN; BRAIN LEVEL; CONTROLLED STUDY; EXCRETION; EXPERIMENTAL BEHAVIORAL TEST; FEMALE; GASTROINTESTINAL EXCRETION; GLOBUS PALLIDUS; HOMEOSTASIS; LIVER LEVEL; LOCOMOTION; MALE; MANGANESE BLOOD LEVEL; MOTOR DYSFUNCTION; MOUSE; NEUROTOXICITY; NONHUMAN; PANCREAS; PONS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; ANALYSIS; ANIMAL; ANIMAL FOOD; DEFICIENCY; DIET; GENETICS; HEP-G2 CELL LINE; HUMAN; KNOCKOUT MOUSE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMAL FEED; ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; CATION TRANSPORT PROTEINS; DIET; HEP G2 CELLS; HOMEOSTASIS; HUMANS; MANGANESE; MICE; MICE, KNOCKOUT; MOTOR DISORDERS; RADIOISOTOPES;

EID: 85042145497     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1806613115     Document Type: Erratum

References (78)

1. Roth J, Ponzoni S, Aschner M (2013) Manganese homeostasis and transport. Met Ions Life Sci 12:169–201.
2. Schroeder HA, Balassa JJ, Tipton IH (1966) Essential trace metals in man: Manganese. A study in homeostasis. J Chronic Dis 19:545–571.
3. O’Neal SL, et al. (2014) Manganese accumulation in bone following chronic exposure in rats: Steady-state concentration and half-life in bone. Toxicol Lett 229:93–100.
4. Davis CD, Zech L, Greger JL (1993) Manganese metabolism in rats: An improved methodology for assessing gut endogenous losses. Proc Soc Exp Biol Med 202: 103–108.
5. Myers JE, et al. (2003) Nervous system effects of occupational manganese exposure on South African manganese mineworkers. Neurotoxicology 24:649–656.
6. Wang D, Du X, Zheng W (2008) Alteration of saliva and serum concentrations of manganese, copper, zinc, cadmium and lead among career welders. Toxicol Lett 176: 40–47.
7. Lucchini R, Bergamaschi E, Smargiassi A, Festa D, Apostoli P (1997) Motor function, olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environ Res 73:175–180.
8. Bader M, Dietz MC, Ihrig A, Triebig G (1999) Biomonitoring of manganese in blood, urine and axillary hair following low-dose exposure during the manufacture of dry cell batteries. Int Arch Occup Environ Health 72:521–527.
9. Srivastava AK, et al. (1991) An investigation of metal concentrations in blood of industrial workers. Vet Hum Toxicol 33:280–282.
10. Nagatomo S, et al. (1999) Manganese intoxication during total parenteral nutrition: Report of two cases and review of the literature. J Neurol Sci 162:102–105.
11. Aschner JL, et al. (2015) Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition. Am J Clin Nutr 102:1482–1489.
12. Butterworth RF, Spahr L, Fontaine S, Layrargues GP (1995) Manganese toxicity, do-paminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 10:259–267.
13. Janocha-Litwin J, Marianska K, Serafinska S, Simon K (2015) Manganese encephalopathy among ephedron abusers. J Neuroimaging 25:832–835.
14. Aschner JL, Aschner M (2005) Nutritional aspects of manganese homeostasis. Mol Aspects Med 26:353–362.
15. Papavasiliou PS, Miller ST, Cotzias GC (1966) Role of liver in regulating distribution and excretion of manganese. Am J Physiol 211:211–216.
16. Horning KJ, Caito SW, Tipps KG, Bowman AB, Aschner M (2015) Manganese is essential for neuronal health. Annu Rev Nutr 35:71–108.
17. Tuschl K, et al. (2016) Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am J Hum Genet 99:521.
18. Quadri M, et al. (2015) Manganese transport disorder: Novel SLC30A10 mutations and early phenotypes. Mov Disord 30:996–1001.
19. Quadri M, et al. (2012) Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am J Hum Genet 90: 467–477.
20. Hutchens S, et al. (2017) Deficiency in the manganese efflux transporter SLC30A10 induces severe hypothyroidism in mice. J Biol Chem 292:9760–9773.
21. Chen P, Bowman AB, Mukhopadhyay S, Aschner M (2015) SLC30A10: A novel manganese transporter. Worm 4:e1042648.
22. Nishito Y, et al. (2016) Direct comparison of manganese detoxification/efflux proteins and molecular characterization of ZnT10 protein as a manganese transporter. J Biol Chem 291:14773–14787.
23. Zogzas CE, Aschner M, Mukhopadhyay S (2016) Structural elements in the trans-membrane and cytoplasmic domains of the metal transporter SLC30A10 are required for its manganese efflux activity. J Biol Chem 291:15940–15957.
24. Leyva-Illades D, et al. (2014) SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. J Neurosci 34:14079–14095.
25. Liu C, et al. (2017) Hypothyroidism induced by loss of the manganese efflux transporter SLC30A10 may be explained by reduced thyroxine production. J Biol Chem 292: 16605–16615.
26. Chen P, Chakraborty S, Peres TV, Bowman AB, Aschner M (2015) Manganese-induced neurotoxicity: From C. elegans to humans. Toxicol Res (Camb) 4:191–202.
27. Menon AV, Chang J, Kim J (2016) Mechanisms of divalent metal toxicity in affective disorders. Toxicology 339:58–72.
28. Veuthey T, Wessling-Resnick M (2014) Pathophysiology of the Belgrade rat. Front Pharmacol 5:82.
29. Illing AC, Shawki A, Cunningham CL, Mackenzie B (2012) Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1. J Biol Chem 287: 30485–30496.
30. Shawki A, et al. (2015) Intestinal DMT1 is critical for iron absorption in the mouse but is not required for the absorption of copper or manganese. Am J Physiol Gastrointest Liver Physiol 309:G635–G647.
31. Chua AC, Morgan EH (1997) Manganese metabolism is impaired in the Belgrade laboratory rat. J Comp Physiol B 167:361–369.
32. Lin W, et al. (2017) Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity. J Clin Invest 127:2407–2417.
33. Taylor KM, Morgan HE, Johnson A, Nicholson RI (2005) Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. FEBS Lett 579: 427–432.
34. Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ (2006) Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci USA 103: 13612–13617.
35. Pinilla-Tenas JJ, et al. (2011) Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron. Am J Physiol Cell Physiol 301:C862–C871.
36. Tuschl K, et al. (2016) Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia. Nat Commun 7:11601.
37. Jenkitkasemwong S, et al. (2015) SLC39A14 is required for the development of he-patocellular iron overload in murine models of hereditary hemochromatosis. Cell Metab 22:138–150.
38. Hardy IJ, Gillanders L, Hardy G (2008) Is manganese an essential supplement for parenteral nutrition? Curr Opin Clin Nutr Metab Care 11:289–296.
39. Kato M (1963) Distribution and excretion of radiomanganese administered to mouse. Q J Exp Physiol Cogn Med Sci 48:355–369.
40. Greenberg DM, Copp DH, Cuthbertson EM (1943) Studies in mineral metabolism with the aid of artificial radioactive isotopes: VII. The distribution and excretion, particularly by way of the bile, of iron, cobalt, and manganese. J Biol Chem 147:749–756.
41. Schramm VL, Brandt M (1986) The manganese(II) economy of rat hepatocytes. Fed Proc 45:2817–2820.
42. Finley JW (1998) Manganese uptake and release by cultured human hepato-carcinoma (Hep-G2) cells. Biol Trace Elem Res 64:101–118.
43. Davidsson L, Lönnerdal B, Sandström B, Kunz C, Keen CL (1989) Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat. J Nutr 119:1461–1464.
44. Nam H, et al. (2013) ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: Implications for tissue iron uptake in iron-related disorders. Haematologica 98:1049–1057.
45. Zheng W, Kim H, Zhao Q (2000) Comparative toxicokinetics of manganese chloride and methylcyclopentadienyl manganese tricarbonyl (MMT) in Sprague-Dawley rats. Toxicol Sci 54:295–301.
46. Meyer LA, Durley AP, Prohaska JR, Harris ZL (2001) Copper transport and metabolism are normal in aceruloplasminemic mice. J Biol Chem 276:36857–36861.
47. Boaru SG, et al. (2014) Simultaneous monitoring of cerebral metal accumulation in an experimental model of Wilson’s disease by laser ablation inductively coupled plasma mass spectrometry. BMC Neurosci 15:98.
48. Sato I, Matsusaka N, Kobayashi H, Nishimura Y (1996) Effects of dietary manganese contents on 54Mn metabolism in mice. J Radiat Res (Tokyo) 37:125–132.
49. Keen CL, Bell JG, Lönnerdal B (1986) The effect of age on manganese uptake and retention from milk and infant formulas in rats. J Nutr 116:395–402.
50. Tucker LB, Fu AH, McCabe JT (2016) Performance of male and female C57BL/6J mice on motor and cognitive tasks commonly used in pre-clinical traumatic brain injury research. J Neurotrauma 33:880–894.
51. Kovács AD, Pearce DA (2013) Location- and sex-specific differences in weight and motor coordination in two commonly used mouse strains. Sci Rep 3:2116.
52. Hojyo S, et al. (2011) The zinc transporter SLC39A14/ZIP14 controls G-protein coupled receptor-mediated signaling required for systemic growth. PLoS One 6:e18059.
53. Aydemir TB, et al. (2012) Zinc transporter ZIP14 functions in hepatic zinc, iron and glucose homeostasis during the innate immune response (endotoxemia). PLoS One 7: e48679.
54. Aydemir TB, Sitren HS, Cousins RJ (2012) The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice. Gastroenterology 142:1536–1546.e5.
55. Wessels I, Cousins RJ (2015) Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation. Am J Physiol Gastrointest Liver Physiol 309:G768–G778.
56. Aydemir TB, et al. (2017) Metal transporter Zip14 (Slc39a14) deletion in mice increases manganese deposition and produces neurotoxic signatures and diminished motor activity. J Neurosci 37:5996–6006.
57. Xin Y, et al. (2017) Manganese transporter Slc39a14 deficiency revealed its key role in maintaining manganese homeostasis in mice. Cell Discov 3:17025.
58. Gibbons RA, et al. (1976) Manganese metabolism in cows and goats. Biochim Biophys Acta 444:1–10.
59. Bertinchamps AJ, Miller ST, Cotzias GC (1966) Interdependence of routes excreting manganese. Am J Physiol 211:217–224.
60. Cotzias GC, Papavasiliou PS (1964) Primordial homeostasis in a mammal as shown by the control of manganese. Nature 201:828–829.
61. Dydak U, et al. (2011) In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect 119:219–224.
62. Fitsanakis VA, et al. (2006) The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity. Neurotoxicology 27:798–806.
63. Racette BA (2014) Manganism in the 21st century: The Hanninen lecture. Neurotoxicology 45:201–207.
64. Carter RJ, et al. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington’s disease mutation. J Neurosci 19:3248–3257.
65. Chesselet MF, Carmichael ST (2012) Animal models of neurological disorders. Neurotherapeutics 9:241–244.
66. Chesselet MF, et al. (2012) A progressive mouse model of Parkinson’s disease: The Thy1-aSyn (“Line 61”) mice. Neurotherapeutics 9:297–314.
67. Janus C, Hernandez C, deLelys V, Roder H, Welzl H (2016) Better utilization of mouse models of neurodegenerative diseases in preclinical studies: From the bench to the clinic. Methods Mol Biol 1438:311–347.
68. Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C, Strazielle C (2002) Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res 956:36–44.
69. Schindowski K, et al. (2006) Alzheimer’s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 169:599–616.
70. Brooks SP, Dunnett SB (2009) Tests to assess motor phenotype in mice: A user’s guide. Nat Rev Neurosci 10:519–529.
71. Roth JA (2014) Correlation between the biochemical pathways altered by mutated Parkinson-related genes and chronic exposure to manganese. Neurotoxicology 44: 314–325.
72. Herrero Hernandez E, et al. (2006) Follow-up of patients affected by manganese-induced parkinsonism after treatment with CaNa2EDTA. Neurotoxicology 27: 333–339.
73. Peres TV, et al. (2015) Developmental exposure to manganese induces lasting motor and cognitive impairment in rats. Neurotoxicology 50:28–37.
74. Takeda A, Sawashita J, Okada S (1995) Biological half-lives of zinc and manganese in rat brain. Brain Res 695:53–58.
75. Hurst JL, West RS (2010) Taming anxiety in laboratory mice. Nat Methods 7:825–826.
76. Rogers DC, et al. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8:711–713.
77. Fleming SM, et al. (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 24:9434–9440.
78. Dunham NW, Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc 46:208–209.